Fresenius Medical Care, a leading provider of products and services for patients with kidney disease, has signed five virtual power purchase agreements with wind and solar energy project developers in the United States and Germany. The wind and solar parks are scheduled to begin operations in 2024 and 2025, and the contracts with Fresenius have terms of 10 to 15 years.

The projects will generate approximately 580 gigawatt hours per year, which is about 46% of Fresenius’ current global energy consumption. The move is a significant step toward the company’s goals of reducing emissions in its operations by 50% by 2030 and achieving climate neutrality by 2040.

Sustainability continues to be a pressing issue in kidney care due to the considerable waste generated by therapies such as dialysis and the impact of climate change-related extreme heat on kidney health.